Current through Vol. 24-16, September 15, 2024
Rule 29.
(1) An
applicant for certification to administer a topical ocular diagnostic
pharmaceutical agent in the practice of optometry shall submit a completed
application, on a form provided by the department, together with the requisite
fee. In addition to meeting the other requirements of the code and the
administrative rules promulgated under the code, an applicant shall satisfy all
of the following requirements:
(a)
Successfully complete a course of study in general and clinical pharmacology
related to the practice of optometry as required in section
17412(2)(a) of
the code, MCL
333.17412. The course of study
must include passing an examination on general and ocular pharmacology. The
applicant has successfully completed the required course of study when the
applicant has been granted the credit hours designated for the course of study
by the teaching institution where the course is offered.
(b) Establish a board-approved emergency
plan, under section
17412(2)(d) of
the code, MCL
333.17412, for the management and
referral of patients who experience any adverse drug reaction. To be
board-approved, the emergency plan must include all of the following:
(i) Patient instructions related to an
adverse drug reaction.
(ii) A
referral procedure for a patient reporting an adverse drug reaction.
(iii) The names and contact information of
not less than 3 physicians, clinics, or hospitals to whom the patient reporting
an adverse drug reaction may be referred.
(iv) A documentation procedure for the
information to be included in the patient's medical record regarding the report
of an adverse drug reaction.
(c) Successfully complete a course in CPR as
required by section
17412(2)(c) of
the code, MCL
333.17412, approved by the
department of health and human services, and offered or approved by any of the
following:
(i) The Red Cross.
(ii) The American Heart
Association.
(iii) An accredited
hospital.
(iv) An organization or
institution comparable to those identified in paragraphs (i) to (iii) of this
subdivision.
(2) A licensed optometrist shall not use
diagnostic pharmaceutical agents in the practice of optometry unless the
optometrist has been certified by the board as being qualified to administer
topical ocular diagnostic pharmaceutical agents.
